Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism

226Citations
Citations of this article
338Readers
Mendeley users who have this article in their library.

Abstract

Objectives The use of doxorubicin, a drug utilised for many years to treat a wide variety of cancers, has long been limited due to the significant toxicity that can occur not only during, but also years after treatment. It has multiple mechanisms of action including the intercalation of DNA, inhibition of topoisomerase II and the production of free radicals. We review the literature, with the aim of highlighting the role of drug concentration being an important determinant on the unfolding cell biological events that lead to cell stasis or death. Methods The PubMed database was consulted to compile this review. Key findings It has been found that the various mechanisms of action at the disposal of doxorubicin culminate in either cell death or cell growth arrest through various cell biological events, such as apoptosis, autophagy, senescence and necrosis. Which of these events is the eventual cause of cell death or growth arrest appears to vary depending on factors such as the patient, cell and cancer type, doxorubicin concentration and the duration of treatment. Conclusions Further understanding of doxorubicin's influence on cell biological events could lead to an improvement in the drug's efficacy and reduce toxicity.

References Powered by Scopus

Anthracyclines: Molecular advances and pharmacologie developments in antitumor activity and cardiotoxicity

3218Citations
N/AReaders
Get full text

Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy

3155Citations
N/AReaders
Get full text

Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems

2031Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications

1202Citations
N/AReaders
Get full text

Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles

183Citations
N/AReaders
Get full text

Autophagy and Doxorubicin resistance in cancer

156Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Meredith, A. M., & Dass, C. R. (2016, June 1). Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. Journal of Pharmacy and Pharmacology. Blackwell Publishing Ltd. https://doi.org/10.1111/jphp.12539

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 98

81%

Researcher 15

12%

Professor / Associate Prof. 5

4%

Lecturer / Post doc 3

2%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 60

51%

Pharmacology, Toxicology and Pharmaceut... 21

18%

Medicine and Dentistry 20

17%

Agricultural and Biological Sciences 17

14%

Save time finding and organizing research with Mendeley

Sign up for free